Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non Dilutive Funding Sources For NVG 291

Press/Media: Press / Media

PeriodOct 19 2020

Media coverage

4

Media coverage

  • TitleEngages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non Dilutive Funding Sources For NVG 291
    Media name/outletMarket News Publishing
    CountryUnited States
    Date10/19/20
    PersonsMichael A Davis
  • TitleNervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291
    Media name/outletTD Ameritrade
    CountryUnited States
    Date10/19/20
    PersonsMichael A Davis
  • TitleNervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291
    Media name/outletMarketScreener.com
    CountryUnited States
    Date10/19/20
    PersonsMichael A Davis
  • TitleNervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291
    Media name/outletPICANTE Today
    CountryRomania
    Date10/19/20
    PersonsMichael A Davis